Literature DB >> 24728835

The effects of Losartan on abdominal wall fascial healing.

C N Criss1, Y Gao, G De Silva, J Yang, J M Anderson, Y W Novitsky, H Soltanian, M J Rosen.   

Abstract

PURPOSE: Losartan, a commonly used angiotensin II receptor blocker (ARB) for blood pressure control, also impairs cutaneous wound healing. Our current study will analyze how Losartan affects wound healing in the muscle and fascia from both biomechanical and histological aspects.
METHODS: A total of 26 Sprague-Dawley rats were separated into one control group (NS, N = 13) and one experimental group (LG, N = 13) to receive normal saline and 40 mg/kg of Losartan by way of gastric lavage, respectively. 7 days later, all animals were subjected to a 5 cm midline laparotomy. The fascia and skin were then closed with 4-0 prolene and 5-0 vicryl. 15 days postoperatively, the animals were sacrificed and the abdominal wall harvested for wound tensiometric test and histological analysis.
RESULTS: All 26 rats survived to the time of necropsy. Tensiometry detected significantly higher wound tensile strength in the NS group (1.6 ± 0.31 N/mm) than in the LG (1.3 ± 0.28 N/mm) group (p = 0.016). Transection histology with trichrome staining demonstrated higher degree of immature fibroplasia inside the wound in the LG group than in the NS group (p = <0.0001). The LG group also had larger incisional gaps than the NG group.
CONCLUSION: The antihypertensive drug, Losartan, retards wound healing in the abdominal fascia and reduces wound tensile strength in our rat model. Attention should be paid to the potential effects of various medications on fascial wound healing to guarantee optimal surgical outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728835     DOI: 10.1007/s10029-014-1241-9

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  28 in total

Review 1.  Use of the wound healing trajectory as an outcome determinant for acute wound healing.

Authors:  M G Franz; M A Kuhn; T E Wright; T L Wachtel; M C Robson
Journal:  Wound Repair Regen       Date:  2000 Nov-Dec       Impact factor: 3.617

2.  Roles of matrix metalloproteinases in the etiology of inguinal hernia.

Authors:  A Aren; A H Gökçe; F S Gökçe; N Dursun
Journal:  Hernia       Date:  2011-07-08       Impact factor: 4.739

3.  Evaluation of the effects of losartan on a random pattern skin flap model in rats.

Authors:  Cemile Nurdan Oztürk; Erdem Tezel; Ozben Yalçın
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2011-03

4.  [Optimization of the preoperative diagnosis of herniated lumbar disks].

Authors:  N A Chudnovskiĭ; E V Desnitskaia
Journal:  Zh Vopr Neirokhir Im N N Burdenko       Date:  1984 Nov-Dec

5.  Angiotensin II regulates collagen metabolism through modulating tissue inhibitor of metalloproteinase-1 in diabetic skin tissues.

Authors:  Meng Ren; Shaoyun Hao; Chuan Yang; Ping Zhu; Lihong Chen; Diaozhu Lin; Na Li; Li Yan
Journal:  Diab Vasc Dis Res       Date:  2013-09       Impact factor: 3.291

6.  Synthesis of type I and III collagen, expression of fibronectin and matrix metalloproteinases-1 and -13 in hernial sac of patients with inguinal hernia.

Authors:  U Klinge; H Zheng; Z Y Si; V Schumpelick; R Bhardwaj; B Klosterhalfen
Journal:  Int J Surg Investig       Date:  1999

7.  Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial.

Authors:  J F Berlauk; J H Abrams; I J Gilmour; S R O'Connor; D R Knighton; F B Cerra
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

8.  The effect of losartan intervention on the regulation of pulmonary arterial collagen expression by protein kinase C in chronic hypoxic rat models.

Authors:  Shaoxian Chen; Hao Zhou; Liangxing Wang
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2002-07

9.  Angiotensin II induces type I collagen gene expression in human dermal fibroblasts through an AP-1/TGF-beta1-dependent pathway.

Authors:  Hong-Tai Tang; Da-Sheng Cheng; Yi-Tao Jia; Dao-Feng Ben; Bing Ma; Kai-Yang Lv; Duo Wei; Zhi-Yong Sheng; Zhao-Fan Xia
Journal:  Biochem Biophys Res Commun       Date:  2009-05-22       Impact factor: 3.575

10.  Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.

Authors:  Shanna A Arnold; Lee B Rivera; Juliet G Carbon; Jason E Toombs; Chi-Lun Chang; Amy D Bradshaw; Rolf A Brekken
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

View more
  4 in total

1.  Detection of Angiotensin II and AT1 Receptor Concentrations in Keloid and Hypertrophic Scar.

Authors:  Feizollah Niazi; Seyed Hassan Hooshyar; Keshvad Hedayatyanfard; Seyed Ali Ziai; Farideh Doroodgar; Sana Niazi; Behnam Habibi; Ali Asadirad
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

2.  Burst inflation test for measuring biomechanical properties of rat abdominal walls.

Authors:  V D Mahalingam; B C Syverud; A M Myers; K W VanDusen; L M Larkin; W M Kuzon; E M Arruda
Journal:  Hernia       Date:  2016-12-30       Impact factor: 4.739

3.  Effects of antihypertensive drugs on surgical outcomes of breast reconstruction: a nationwide population-based claim study.

Authors:  Jin-Woo Park; Hae Yeon Park; Minsu Park; Mi Yang; Goo-Hyun Mun
Journal:  Gland Surg       Date:  2021-07

4.  Losartan modifies mesh integration after abdominal wall repair: an experimental study.

Authors:  M E Peña; C A Angeramo; F Schlottmann; E E Sadava
Journal:  Hernia       Date:  2021-06-17       Impact factor: 2.920

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.